Rachel Frank | executive |
Sanj Patel | executive |
Ross Moat | executive |
John Paolini | executive |
Mark Ragosa | executive |
Anupam Rama | analyst |
Kyuwon Choi | analyst |
Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Rachel Frank, Head of Investor Relations. Please go ahead.
Thank you, operator. Good morning, everyone, and thank you for Kiniksa's call to discuss our fourth quarter and full year 2023 financial results and recent portfolio execution.